Interestingly, iCAFs promote polarization of M2 TAMs on one hand, and increase the number of myeloid-derived suppressor cells (MDSCs) in the tumor on the other, leading to a decrease in CD8+ cytotoxic T cells [56,57]. The gene discussed is CD8A; the disease is neoplasm.